Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes

Breast Cancer Research and Treatment

Volumn 131, Issue 2, 2012, Pages 527-540

  Kim, Jiyoung ^a   Lee, Sekyung ^a   Bae, Sooyoun ^b   Choi, Min Young ^a   Lee, Jeonghui ^a   Jung, Seung Pil ^a   Kim, Sangmin ^a   Choe, Jun Ho ^a   Kim, Jung Han ^a   Kim, Jee Soo ^a   Lee, Jeong Eon ^a   Nam, Seok Jin ^a   Yang, Jung Hyun ^b  

^a Sungkyunkwan University   (South Korea)

^b Konkuk University Hospital   (South Korea)

Author keywords

Breast cancer; Molecular subtype; Prognosis; Screen detected

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; HORMONE RECEPTOR;

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SOUTH KOREA; SYMPTOM; TRIPLE NEGATIVE BREAST CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84856221264     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1836-0     Document Type: Article

References (41)

1. H Joensuu T Lehtimaki K Holli L Elomaa T Turpeenniemi-Hujanen V Kataja A Anttila M Lundin J Isola J Lundin 2004 Risk for distant recurrence of breast cancer detected by mammography screening or other methods JAMA 292 1064 1073 15339900 10.1001/jama.292.9.1064 1:CAS:528:DC%2BD2cXnsVOgsL0%3D (Pubitemid 39129196)
2. Y Shen Y Yang LY Inoue MF Munsell AB Miller DA Berry 2005 Role of detection method in predicting breast cancer survival: analysis of randomized screening trials J Natl Cancer Inst 97 1195 1203 16106024 10.1093/jnci/dji239 (Pubitemid 41258225)
3. M Kalager T Haldorsen M Bretthauer G Hoff SO Thoresen HO Adami 2009 Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study Breast Cancer Res 11 R44 19575807 10.1186/bcr2331
4. DA Berry KA Cronin SK Plevritis DG Fryback L Clarke M Zelen JS Mandelblatt AY Yakovlev JD Habbema EJ Feuer 2005 Effect of screening and adjuvant therapy on mortality from breast cancer Engl J Med 353 1784 1792 10.1056/NEJMoa050518 1:CAS:528:DC%2BD2MXhtFKrtLbN (Pubitemid 41549890)
5. S Mook LJ Van 't Veer EJ Rutgers PM Ravdin AO van de Velde FE van Leeuwen O Visser MK Schmidt 2011 Independent prognostic value of screen detection in invasive breast cancer J Natl Cancer Inst 103 585 597 21350218 10.1093/jnci/djr043
6. SJ Dawson SW Duffy FM Blows KE Driver E Provenzano J LeQuesne DC Greenberg P Pharoah C Caldas GC Wishart 2009 Molecular characteristics of screen-detected vs. symptomatic breast cancers and their impact on survival Br J Cancer 101 1338 1344 19773756 10.1038/sj.bjc.6605317 1:CAS:528: DC%2BD1MXht1GntbnL
7. H Sihto J Lundin T Lehtimaki M Sarlomo-Rikala R Butzow K Holli L Sailas V Kataja M Lundin T Turpeenniemi-Hujanen J Isola P Heikkila H Joensuu 2008 Molecular subtypes of breast cancers detected in mammography screening and outside of screening Clin Cancer Res 14 4103 4110 18593987 10.1158/1078-0432. CCR-07-5003 1:CAS:528:DC%2BD1cXnvFylu74%3D
8. ID Nagtegaal PC Allgood SW Duffy O Kearins EO Sullivan N Tappenden M Wallis G Lawrence 2011 Prognosis and pathology of screen-detected carcinomas: how different are they? Cancer 117 1360 1368 21425135 10.1002/cncr.25613
9. DL Weaver RD Rosenberg WE Barlow L Ichikawa PA Carney K Kerlikowske DS Buist BM Geller CR Key SJ Maygarden R Ballard-Barbash 2006 Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography Cancer 106 732 742 16411214 10.1002/cncr.21652 (Pubitemid 43238438)
10. MF Ernst JA Roukema JW Coebergh OJ Repelaer van Driel MW van Beek MJ van der Sangen AC Voogd 2002 Breast cancers found by screening: earlier detection, lower malignant potential or both? Breast Cancer Res Treat 76 19 25 12408372 10.1023/A:1020213817562 1:CAS:528:DC%2BD38XntVKjtb8%3D (Pubitemid 35178625)
11. PC Allgood SW Duffy O Kearins E O'Sullivan N Tappenden MG Wallis G Lawrence 2011 Explaining the difference in prognosis between screen-detected and symptomatic breast cancers Br J Cancer 104 1680 1685 21540862 10.1038/bjc.2011.144 1:STN:280:DC%2BC3MrkslahsQ%3D%3D
12. GB Hutchison S Shapiro 1968 Lead time gained by diagnostic screening for breast cancer J Natl Cancer Inst 41 665 681 5677315 1:STN:280: DyaF1cvhtFamtQ%3D%3D
13. S Shapiro JD Goldberg GB Hutchison 1974 Lead time in breast cancer detection and implications for periodicity of screening Am J Epidemiol 100 357 366 4417355 1:STN:280:DyaE2M%2FhvVChsw%3D%3D
14. PH Zahl BH Strand J Maehlen 2004 Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study BMJ 328 921 924 15013948 10.1136/bmj.38044.666157.63 (Pubitemid 38496981)
15. GC Wishart DC Greenberg PD Britton P Chou CH Brown AD Purushotham SW Duffy 2008 Screen-detected vs. symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer 98 1741 1744 18506175 10.1038/sj.bjc.6604368 1:STN:280:DC%2BD1czkt1GlsA%3D%3D (Pubitemid 351748836)
16. C Sotiriou SY Neo LM McShane EL Korn PM Long A Jazaeri P Martiat SB Fox AL Harris ET Liu 2003 Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 100 10393 10398 12917485 10.1073/pnas.1732912100 1:CAS:528:DC%2BD3sXntFynsrk%3D (Pubitemid 37071889)
17. PL Nguyen AG Taghian MS Katz A Niemierko RF Abi Raad WL Boon JR Bellon JS Wong BL Smith JR Harris 2008 Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2373 2378 18413639 10.1200/JCO.2007.14.4287
18. T Sorlie R Tibshirani J Parker T Hastie JS Marron A Nobel S Deng H Johnsen R Pesich S Geisler J Demeter CM Perou PE Lonning PO Brown AL Borresen-Dale D Botstein 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 12829800 10.1073/pnas.0932692100 1:CAS:528:DC%2BD3sXlsFGntLk%3D (Pubitemid 36842560)
19. T Sorlie CM Perou R Tibshirani T Aas S Geisler H Johnsen T Hastie MB Eisen M van de Rijn SS Jeffrey T Thorsen H Quist JC Matese PO Brown D Botstein P Eystein Lonning AL Borresen-Dale 2001 Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 98 10869 10874 11553815 10.1073/pnas.191367098 1:CAS:528: DC%2BD3MXntVGmsbo%3D (Pubitemid 32878711)
20. CM Perou T Sorlie MB Eisen M van de Rijn SS Jeffrey CA Rees JR Pollack DT Ross H Johnsen LA Akslen O Fluge A Pergamenschikov C Williams SX Zhu PE Lonning AL Borresen-Dale PO Brown D Botstein 2000 Molecular portraits of human breast tumours Nature 406 747 752 10963602 10.1038/35021093 1:CAS:528: DC%2BD3cXmt1CnsLw%3D
21. J Jacquemier C Ginestier J Rougemont VJ Bardou E Charafe-Jauffret J Geneix J Adelaide A Koki G Houvenaeghel J Hassoun D Maraninchi P Viens D Birnbaum F Bertucci 2005 Protein expression profiling identifies subclasses of breast cancer and predicts prognosis Cancer Res 65 767 779 15705873 1:CAS:528:DC%2BD2MXhtVWntrY%3D (Pubitemid 40216434)
22. NA Makretsov DG Huntsman TO Nielsen E Yorida M Peacock MC Cheang SE Dunn M Hayes M van de Rijn C Bajdik CB Gilks 2004 Hierarchical clustering analysis of tissue microarray immunostaining data identifies prognostically significant groups of breast carcinoma Clin Cancer Res 10 6143 6151 15448001 10.1158/1078-0432.CCR-04-0429 1:CAS:528:DC%2BD2cXnvVOjs70%3D (Pubitemid 39287520)
23. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual, 7th edn. Springer, New York
24. HJ Bloom WW Richardson 1957 Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years Br J Cancer 11 359 377 13499785 10.1038/bjc.1957.43 1:STN:280:DyaG1c%2Fkt1Gmtg%3D%3D
25. M Colozza A Sidoni M Piccart-Gebhart 2010 Value of Ki67 in breast cancer: the debate is still open Lancet Oncol 11 414 415 20434714 10.1016/S1470- 2045(10)70089-9
26. KW Jung S Park HJ Kong YJ Won JY Lee EC Park JS Lee 2011 Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008 Cancer Res Treat 43 1 11 21509157 10.4143/crt.2011.43.1.1
27. Korean Breast Cancer Society (2008) 2006-2008 Breast cancer facts & figures. Korean Breast Cancer Society, Seoul
28. SM Lim HY Lee KS Choi JK Jun EC Park Y Kim MA Han DK Oh JI Shim 2010 Trends of mammography use in a national breast cancer screening program, 2004-2008 Cancer Res Treat 42 199 202 21253321 10.4143/crt.2010.42.4.199
29. DK Oh JI Shim M Han Y Kim HY Lee JK Jun KS Choi EC Park 2010 Breast cancer screening in Korean women: report of the national cancer screening program in 2008 J Breast Cancer 13 299 304 10.4048/jbc.2010.13.3.299
30. J Bastos B Peleteiro J Gouveia MP Coleman N Lunet 2010 The state of the art of cancer control in 30 European countries in 2008 Int J Cancer 126 2700 2715 19830695 1:CAS:528:DC%2BC3cXjvFKls7o%3D
31. TJ Anderson J Lamb P Donnan FE Alexander A Huggins BB Muir AE Kirkpatrick U Chetty W Hepburn A Smith, et al. 1991 Comparative pathology of breast cancer in a randomised trial of screening Br J Cancer 64 108 113 1854609 10.1038/bjc.1991.251 1:STN:280:DyaK3Mzgsl2htA%3D%3D
32. A Lindgren L Holmberg E Thurfjell 1997 The influence of mammography screening on the pathological panorama of breast cancer APMIS 105 62 70 9063503 10.1111/j.1699-0463.1997.tb00541.x 1:STN:280:DyaK2s3hslCrsA%3D%3D (Pubitemid 27504558)
33. MA de Roos B van der Vegt J de Vries J Wesseling GH de Bock 2007 Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast Ann Surg Oncol 14 2097 2104 17453296 10.1245/s10434-007-9395-7 (Pubitemid 46988264)
34. WK Cowan P Kelly A Sawan WJ Cunliffe L Henry MJ Higgs LG Lunt JR Young CH Horne B Angus 1997 The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study J Pathol 182 29 35 9227339 10.1002/(SICI)1096-9896(199705)182:1<29::AID-PATH820>3.0.CO;2- # 1:CAS:528:DyaK2sXjvFyksbs%3D (Pubitemid 27240446)
35. KC Chu CR Smart RE Tarone 1988 Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial J Natl Cancer Inst 80 1125 1132 3411625 10.1093/jnci/80.14.1125 1:STN:280: DyaL1czhslSjtA%3D%3D
36. WK Cowan B Angus J Henry IP Corbett WA Reid CH Horne 1991 Immunohistochemical and other features of breast carcinomas presenting clinically compared with those detected by cancer screening Br J Cancer 64 780 784 1680369 10.1038/bjc.1991.398 1:STN:280:DyaK38%2FgtFeiuw%3D%3D
37. E Paci A Ponti M Zappa S Patriarca P Falini G Delmastro S Bianchi A Sapino V Vezzosi C Senore E Crocetti A Frigerio R Zanetti MR Del Turco N Segnan 2005 Early diagnosis, not differential treatment, explains better survival in service screening Eur J Cancer 41 2728 2734 16239106 10.1016/j.ejca.2005.06.026 (Pubitemid 41607566)
38. Biesheuvel C, Czene K, Orgeas CC, Hall P (2011) The role of mammography screening attendance and detection mode in predicting breast cancer survival-Is there added prognostic value? Cancer Epidemiol (in press). doi: 10.1016/j.canep.2011.02.008
39. PG Gill 2004 Detection by screening mammography is a powerful independent predictor of survival in women diagnosed with breast cancer Breast 13 15 22 14759711 10.1016/S0960-9776(03)00169-3 1:STN:280:DC%2BD2c%2FlvVGjsQ%3D%3D (Pubitemid 38228583)
40. JH Todd C Dowle MR Williams CW Elston IO Ellis CP Hinton RW Blamey JL Haybittle 1987 Confirmation of a prognostic index in primary breast cancer Br J Cancer 56 489 492 3689666 10.1038/bjc.1987.230 1:STN:280:DyaL1c%2FnslKlug%3D%3D (Pubitemid 17146357)
41. A Miles J Cockburn RA Smith J Wardle 2004 A perspective from countries using organized screening programs Cancer 101 1201 1213 15316915 10.1002/cncr.20505 (Pubitemid 39100414)